برخی از فایلهای دیداری این پادکست ممکن است خراب باشد.
Maybe this podcast has a new rss feed?
درباره این پادکست 🔗
REMAP-CAP uses an innovative trial design to efficiently evaluate multiple interventions simultaneously. During this podcast you will get to know the people behind the REMAP-CAP family, why research is in our DNA, how to set up an adaptive trial, and much more.
فرکانس به روز رسانی:
every 39 days
میانگین طول صدا:
42 minutes
انگلیسی
ایالات متحده آمریکا
9 قسمت
از سال 7 سپتامبر 2020
episodic
آخرین اپیزود 🔗
Critical Care Reviews’ Rob Mac Sweeney talks with Prof. Alistair Nichol about ivermectin, one of the latest interventions added to the REMAP-CAP trial. He explains why this intervention is implemented into the trial despite the controversy surrounding the use of ivermectin to treat COVID-19.
جستجوی اپیزودهای گذشته
اپیزودهای قبلی REMAP-CAP را جستجو کن.
اپیزود قبلی 🔗
Critical Care Reviews’ Rob Mac Sweeney talks with Dr. Lennie Derde about her background in critical care, infectious diseases and research, all the output generated by REMAP-CAP so far and her view on how this pandemic is likely to progress.
Critical Care Reviews’ Rob Mac Sweeney talks with professor Derek Angus about the interaction between clinical research and clinical practice.
Critical Care Reviews’ Rob Mac Sweeney talks with professor Alistair Nichol about the new Ventilation domain of REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with professor Mathias Pletz about pandemics and the COVID-19 pandemic mode of REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with Dr. Scott Berry about the statistical plan of REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with professor John Marshall and assistant professor Srinivas Murthy about the interventions in REMAP-CAP.
Critical Care Reviews’ Rob Mac Sweeney talks with professor Steve Webb about the design of REMAP-CAP. In this episode we describe the rationale behind the trial and its origin.
Together with Derek Angus and Tony Gordon, Rob Mac Sweeney dives into the first results of the REMAP-CAP trial and the launch of the first manuscript in JAMA. In this episode we discuss the methodology of the trial and the results of this manuscript.
شما تمام اپیزودهای این پادکست را دیده‌اید
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به REMAP-CAP است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,828,185و قسمت های196,365,349بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
سرمایه‌گذاری روی دانش بیشترین بازده را دارد؛ پس پادکست گوش می‌دهم.
‐ Benjamin "Llamacorn" Franklin
جستجوی اپیزودهای گذشته
اپیزودهای قبلی REMAP-CAP را جستجو کن.
مدعی این پادکست شوید
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post آگهی‌های طبقه‌بندی‌شده for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
مصاحبه با پادکستر...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
حساب رسمی X ما (که قبلاً Twitter بود) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
